- Notice
- Hyper Interdisciplinary Conference
Call for Participants] [Osaka Conference of the Society of Hyperdifferent Fields] If You Understand Autophagy, Can You Understand Health Indicators? The story behind the trump card of personal health care from Japan / April 24, 2021, 14:00-@Osaka City
2021.04.01
A story about the trump card of personal health care from Japan
A panel discussion, "If we can understand autophagy, can we understand health indicators? -Story about the trump card of personal health care from Japan-" (session partner: Nihon Unisys, Ltd.) will be held.
There is one area of research in which Japan clearly leads the world. It is autophagy, a topic for which Professor Yoshinori Osumi was awarded the 2016 Nobel Prize in Physiology or Medicine. This mechanism by which cells break down and recycle proteins is thought to prevent our cells from aging. It is hoped that a deeper understanding of autophagy will lead to the creation of new indicators, supplements, and drugs to extend healthy lifespan in a way that suits each individual. In this session, we will welcome Mr. Ishido, President of AutoPhagyGo (APGO), a biotech venture company that promotes autophagy research from all aspects, Mr. Matsukawa, Executive Officer of UHA Ajikakugasugar, who developed products with APGO, and Mr. Haneda, Fellow of Nihon Unisys, who has been working on utilizing healthcare data in recent years. Fellow of Nihon Unisys, which has been working on the use of healthcare data in recent years, will join the panel to discuss what kind of health indicators we can construct in the future by utilizing autophagy-related data. The moderator will be Inoue, CTO of Liverness.
We have prepared a program of discussions among researchers, startups, and large companies from a variety of perspectives, not limited to the themes of this session. We are now accepting applications for the audience, so please join us.The information is available on the convention website (see below).
If we can understand autophagy, can we understand health indicators?
A story about the trump card of personal health care from Japan
Date: Saturday, April 24, 2021, 14:00-15:00
Location:Maruzen Intec Arena Osaka (3-1-40 Tanaka, Minato-ku, Osaka, 552-0005, Japan (in Hachimanya Park)
Details:https://hic.lne.st/conference/hic2021/
speaker
Nihon Unisys, Ltd.
fellow
Akihiro Hada
Joined Nippon Univac (now Nihon Unisys) in 1984. He worked in the R&D department, researching new technologies in areas such as simulation and demand forecasting, and the practical application of systems. He then worked as an IT consultant for corporate systems, mainly in the manufacturing and financial industries, and has been in charge of research and development since 2007. His main publications include ENIAC Frontiers of Modern Computational Technology (2016, co-translation, Kyoritsu Publishing).
AutoPhagyGO, Inc.
President and Representative Director
Miwako Ishido
Graduated from the University of Tokyo, Faculty of Science, and Kyoto University. Doctor of Science. After working as a post-doctoral fellow at The Scripps Research Institute and as a senior researcher at R & R Corporation, he worked in marketing and medical affairs at foreign pharmaceutical companies Janssen Pharma K.K. and AbbVie LLC From 2019, he will also serve as a director of AutoPhagyGO Inc. Since June 2020, he has been dedicated to the position of President and Representative Director of AutoPhagyGO, Inc.
UHA AJI-GOKUSAI Co.
Deputy Leader, Bio Development Division
Executive Officer
Taiji Matsukawa
He received his Master's degree from the Graduate School of Agriculture, Kyoto University. After working at the research institute of Meiji Dairies Corporation and the Food Development Laboratory, he joined UHA AJIKAKU Sugar Co. After engaging in product development of confectioneries, he launched a new health care business. In 2016, he was appointed as Executive Officer, and from March 2020, he will also serve as Deputy Leader of the Bio Development Division.
.
Leave a Nest Co., Ltd.
Representative Director, Vice President CTO
Joe Inoue
D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. After completing the doctoral program, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, and as an assistant professor at the Graduate School of Medicine, Kyoto University before becoming a specially-appointed associate professor at the Institute for Advanced Biosciences, Keio University in 2015 and a professor at the Faculty of Pharmaceutical Sciences, Kumamoto University in 2018. While conducting research and development, he is a researcher involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes.